<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Hahn S</dc:creator>
  <dc:creator>Erb P</dc:creator>
  <dc:date>1999</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Among the CD4-positive (CD4+) T-lymphocytes a population exists which expresses cytolytic activity. These 'killer' cells belong to the T helper type 1 (Th1) subset and if activated, express Fas-ligand (FasL) which induces apoptosis in Fas-positive target cells. The major targets of these CD4+ cytotoxic T-lymphocytes (CTL) are cells of the immune system, such as T, B cells and macrophages which express Fas upon activation. Thus, CD4+ CTL play a major immunoregulatory part through the elimination of activated myeloid and lymphoid cells during and upon completion of an immune response. In certain diseases, such as in HIV-infection and some autoimmune disorders, the functional activity of CD4+ CTL is disturbed preferentially at the level of FasL-Fas interaction, further emphasizing their important immunoregulatory role. Furthermore, Fas-ligand expressing tumors can evade the attack of Fas-positive CD4+ CTL and other effector cells, thereby giving them an opportunity to expand.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/142796</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.3109/08830189909088493</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/10672496</dc:relation>
  <dc:source>International reviews of immunology. - 1999</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Adjuvants, Immunologic</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Animals</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">CD4 Antigens</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">CD4-Positive T-Lymphocytes</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Immunity</dc:subject>
  <dc:title xmlns:ns7="xml" ns7:lang="en">The immunomodulatory role of CD4-positive cytotoxic T-lymphocytes in health and disease.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
